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Human enteroviruses and rhinoviruses rapidly and selectively abolish translation from cellular mRNA upon infection of
susceptible cells. Expression of the poliovirus 2A protease (PV 2Apro) is sufficient to cause host translation shutoff through
cleavage of eIF4G (formerly p220, eIF4g) either directly or indirectly through activation of a cellular factor. Evidence exists
for both direct and indirect cleavage mechanisms; however, factors presumed to participate in an indirect mechanism have
not yet been purified or defined. Here we show that the dominant eIF4G cleavage activity in lysates from infected HeLa cells
was separable from PV 2Apro by size exclusion chromatography. 2Apro separated into two peak fractions which contained
activity which cleaved a peptide substrate derived from the poliovirus polyprotein. These peak 2Apro fractions did not cleave
eIF4G or an eIF4G-derived peptide, as expected, due to the poor efficiency of direct cleavage reactions. Conversely, fractions
which contained peak eIF4G cleavage activity and only trace amounts of 2Apro efficiently cleaved a peptide substrate derived
from the previously mapped eIF4G cleavage site and also cleaved a peptide derived from the poliovirus 1D2A region. The
dominant eIF4G cleavage activity was highly purified through four chromatography steps and found to be devoid of all traces
of 2Apro or its precursors. Quantitation of 2Apro from lysates of infected cells showed that during infections in HeLa cells,
2Apro does not reach molar excess over eIF4G, as previously shown to be required for direct eIF4G cleavage in vitro. Further,
infection of HeLa cells in the presence of 2 mM guanidine–HCl, a potent inhibitor of viral RNA replication, suppressed
accumulation of 2Apro and its precursor 2ABC below detectable levels but was unable to delay the onset of eIF4G proteolysis
in vivo. The eIF4G cleavage activity was still easily detectable in in vitro assays using fractions from guanidine-treated cells.
Thus, the data suggest that poliovirus utilizes two catalytic activities to ensure rapid cleavage of eIF4G in vivo. Although it
was not directly measurable here, 2Apro likely does cleave a portion of eIF4G in cells. However, the data suggest that a
cellular factor which can be activated by small quantities of 2Apro constitutes the bulk of the eIF4G-specific cleavage activity
in infected cells and is responsible for the rapid and efficient eIF4G cleavage activity observed in vivo. © 1998 Academic Press
INTRODUCTION
Most members of the picornavirus family inactivate
translation of cellular mRNA in infected cells through a
mechanism that includes the proteolysis of eukaryotic
translation initiation factor 4G (eIF4G, previously referred to
as eIF4g or p220) (Devaney et al., 1988; Etchison and Fout,
1985; Etchison et al., 1982). This protein possesses binding
sites for eIF3 as well as the m7GTP cap-binding protein,
eIF4E (Lamphear et al., 1995; Pestova et al., 1996), thus
providing a link between capped cellular mRNA and eIF3
complexed with the 40S ribosomal subunit. Within 2 h after
enterovirus infection of most susceptible cell types all the
eIF4G is rapidly converted into a set of smaller, antigeni-
cally related cleavage products. At nearly the same time
host protein synthesis is abruptly halted and viral mRNA
translation continues via a cap-independent mechanism in
which ribosomes bind through recognition of internal viral
RNA sequences (See Belsham and Sonenberg, 1996;
Ehrenfeld, 1996, for recent reviews). Interestingly, in
some experimental systems host protein synthesis is
supressed by only 50% or less, despite complete eIF4G
cleavage (Benton et al., 1995; Bonneau and Sonenberg,
1987; Lloyd and Bovee, 1993; Lloyd et al., 1987; Perez and
Carrasco, 1991). This imperfect correlation between
eIF4G cleavage and host cell translational shutoff sug-
gests that while eIF4G cleavage is required for shutoff to
occur, at least one other event is involved in the total
inactivation of translation of host-encoded mRNA in in-
fected cells.
Over the past decade the central role of the viral 2A
protease (2Apro) in eIF4G cleavage has been investi-
gated, and data acquired using different experimental
approaches have led to the proposal of two models for
eIF4G cleavage. It has been clearly demonstrated that
the poliovirus (PV) 2Apro is the only viral protein required
for activating eIF4G cleavage (Bernstein et al., 1985;
Kra¨usslich et al., 1987; Lloyd et al., 1988). However, early
on it was shown that the majority of PV 2Apro does not
comigrate with eIF4G-specific cleavage activity upon
subcellular fractionation of infected cells, and an anti-2A
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antiserum which blocks viral polyprotein processing by
2Apro does not inhibit eIF4G cleavage in vitro (Lloyd et al.,
1986; Kra¨usslich et al., 1987). Conversely, several recent
studies have demonstrated that the purified 2Apro of
coxsackievirus type B4 (CVB) and human rhinovirus
(HRV) (Haghighat et al., 1996; Lamphear et al., 1993;
Liebig et al., 1993; Sommergruber et al., 1994), as well as
poliovirus (PV) (Bovee et al., 1998), can utilize eIF4G as a
substrate in vitro, although the cleavage efficiency of
these reactions was very low. While these reports
showed that direct catalysis of eIF4G cleavage can occur
in vitro, the inefficiency of reactions appear inconsistent
with the rapid and efficient cleavage of eIF4G observed
in vivo for these picornaviruses (Etchison et al., 1982;
Kirchweger et al., 1994). Thus, it is not known whether
direct cleavage by 2Apro simply occurs much more effi-
ciently in vivo than has been measured in vitro reactions
due to alteration of eIF4G substrate or a unique micro-
environment or whether a more efficient cleavage mech-
anism involving a cellular factor is operative in vivo.
Furthermore, since the data supporting the involvement
of an additional cellular factor (an indirect cleavage
mechanism) have been derived solely from studies of
PV-infected cells, it has been proposed (Haller and Sem-
ler, 1995) that PV uses a mechanism for activation of
eIF4G proteolysis different from that employed by CVB
and HRV.
For this study, we examined in more detail the eIF4G-
specific cleavage mechanism in PV-infected HeLa cells.
In particular, we focused on the relative contribution of
2Apro and other proteolytic factors to the total eIF4G
cleavage observed. We report here that radiolabeled PV
2Apro did not copurify through size exclusion chromatog-
raphy with the eIF4G-specific cleavage activity measur-
able in infected HeLa cell lysate. We also purified the
dominant eIF4G-specific cleavage activity from PV-in-
fected cells to a very high level and showed that it
contained no measurable 2Apro. In addition we deter-
mined that the level of 2Apro present in PV-infected HeLa
cell lysate at early or late timepoints during infection was
insufficient to cleave significant amounts of eIF4G via
direct catalysis. Last, we showed that the presence of
guanidine during infection drastically reduced produc-
tion of 2Apro to undetectable levels, yet did not signifi-
cantly delay the rapid in vivo cleavage of eIF4G. These
data strongly suggest that a highly active cellular pro-
tease supplements 2Apro to result in the efficient in vivo
cleavage of eIF4G.
RESULTS
The primary eIF4G cleavage activity in infected cell
lysate segregates from PV 2Apro
Purified and/or recombinant forms of 2Apro and eIF4G
have been used previously to demonstrate that direct
proteolysis of eIF4G occurs in vitro (Haghighat et al.,
1996; Lamphear et al., 1993; Liebig et al., 1993; Sommer-
gruber et al., 1994); however, typical in vitro cleavage
reactions required high enzyme concentrations and mo-
lar excess of 2Apro over substrate to cause complete
cleavage. This is in contrast to the rapid and efficient
eIF4G cleavage observed in vivo (Etchison et al., 1982;
Kirchweger et al., 1994).
To address the issue of in vivo eIF4G cleavage, we
have focused on the dominant eIF4G cleavage activity
which can be easily detected in infected cells and tested
whether this activity was associated with 2Apro. We also
wanted to test whether native 2Apro in cell lysates could
be demonstrated to contain this dominant cleavage ac-
tivity. Thus, we have more completely characterized the
subcellular fractionation of PV 2Apro, which was previ-
ously shown to be evenly distributed between the insol-
uble membrane-containing P10 compartment and the
soluble S10 compartment. Further fractionation of the
S10 into the high-speed supernate (S200), ribosomal salt
wash (RSW), and washed ribosome pellet (SWRibo) frac-
tions allowed enrichment of eIF4G cleavage activity
which could be further concentrated by 40% ammonium
sulfate precipitation (Lloyd et al., 1987). These fractions
were also assessed here for both eIF4G cleavage activ-
ity and presence of 2Apro, as shown in Table 1. The data
show that while 2Apro associates closely with insoluble
TABLE 1
Subcellular Fractionation of 2Apro and eIF4G Cleavage Activity
Fractionb S10 P10 S200 SW Ribo RSW
% Total 2A content 46 54 10 32 3.3
eIF4G cleavage activity (U/109 cell eq.) 14.3 4.5 4.7 0.1 9.6
% Total eIF4G cleavage activity 76 24 25 ,1 51
Note. Values were quantitated using densitometry of scanned immunoblots and autoradiographs with the program NIH Image. Values were
averaged from several experiments and are expressed in terms of cleavage units per 109 cell equivalents and the percentage of the total found in
the whole cell. Activity units were estimated from immunoblots of cleavage reactions containing dilutions of cell fractions and are defined as the
amount of cleavage activity required to cleave 50% of the eIF4G present in a 5-ml ribosomal salt wash sample in 90 min at 37°C.
a Fractions were derived as under Materials and Methods: S10, postmitochondrial supernate; P10, postmitochondrial pellet; S200, post ribosomal
supernate; SW Ribo, salt-washed ribosome pellet, RSW, ribosomal salt wash.
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proteins and membranes in the P10 and SWRibo pellet
fractions, the majority of eIF4G cleavage activity is asso-
ciated with the soluble S200 and RSW fractions. In par-
ticular the SW Ribo fraction contains approximately 32%
of the total 2Apro content of the cell, yet no eIF4G cleav-
age activity is detected in this fraction. No fractions
prepared in a similar fashion from mock-infected cells
contain detectable eIF4G cleavage activity.
We then tested whether eIF4G cleavage activity could
be chromatographically separated from 2Apro. The S200
A-cut and RSW A-cut fractions were chosen because
they contained the most concentrated eIF4G cleavage
activity and limited but detectable amounts of 2Apro, and
their purity relative to crude lysate allowed better reso-
lution by HPLC. These samples were independently
chromatographed on a SW3000 gel filtration column (Fig.
1). Figure 1A shows the elution profile of radiolabeled
2Apro from the S200 A-cut fraction. Interestingly, 2Apro in
the S200 fraction was detected in all fractions, yet con-
centrated into several peaks which eluted with apparent
molecular masses of approximately 200, 75, 30, and 17
kDa, from left to right (lanes 1–2, 8–9, 13, 16–17). The
majority of 2Apro was found in the large molecular weight
fraction (lanes 1–2), apparently in some state of aggre-
gation or complexed with other unknown molecules.
Importantly, neither this fraction, nor any of the other
peak fractions enriched for 2Apro, possessed measur-
able eIF4G cleavage activity. Unlike the polyphasic mi-
gration of 2Apro, eIF4G cleavage activity was centered
around a single peak near 50 kDa (lanes 10–12) and did
not correspond to fractions containing the most 2Apro.
Similar analysis of the chromatographed RSW A-cut (Fig.
1B) showed 2Apro migrating almost exclusively in the
expected 17-kDa range, but the eIF4G cleavage activity
peak again was associated with fractions in the 50-kDa
size range, which contained only trace levels of 2Apro.
Although some direct cleavage of eIF4G by the 2Apro-
enriched column fractions might have been expected, it
was likely not observed because we and others have
shown previously that substantial direct catalysis of
eIF4G cleavage requires molar excess of 2Apro, which
was not present in these assays (Bovee et al., 1998;
Haghighat et al., 1996; Lamphear et al., 1993; Liebig et al.,
1993; Sommergruber et al., 1994). Importantly, analysis of
autoradiographs also revealed that the 2Apro precursor
2ABC was only detected in high-molecular-weight frac-
tions (S200 fractions 1–9 or RSW fractions 1–5); thus,
FIG. 1. Size exclusion chromatography of radiolabeled PV-infected HeLa lysate fractions. Radiolabeled S200 A-cut (top) and the RSW A-cut (bottom)
subcellular fractions were separately chromatographed on an SW3000 column and fractions were subjected to SDS–PAGE and autoradiographed for 25
days, as described under Materials and Methods. Short exposures of the respective HPLC start samples are shown (lane ST). 35 ml of each fraction was
assayed for eIF4G cleavage activity as described in Table 1 and total units were calculated for the entire fraction. Chromatographic migration peaks for
molecular weight standards are indicated between panels: blue dextran, .200 kDa; bovine serum albumin, 66 kDa; ovalbumin, 45 kDa; RNase A, 17 kDa.
SDS–PAGE mobilities of 2Apro and other viral proteins are labeled relative to molecular weight standards. 2Apro is marked by an arrowhead.
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2ABC did not comigrate with eIF4G cleavage activity
(data not shown).
2Apro-enriched cell fractions cleave a viral
polyprotein-derived peptide but not an
eIF4G-derived peptide
We have previously used a peptide containing the
native 1D2A junction polyprotein cleavage site sequence
for sensitive assay of 2Apro activity (Alvey et al., 1991;
Bovee et al., 1998). Further we have recently shown that
this assay is at least a 10-fold more sensitive indicator of
2Apro activity than eIF4G cleavage assays, requiring only
1 nM enzyme (Bovee et al., 1998). Thus, we attempted to
probe for trace amounts of highly active 2Apro in fractions
containing peak eIF4G cleavage activity by assaying for
proteolysis of the PV 1D2A peptide. For these activity
assays the crude PV-infected S10 lysate was passed
over a Sephacryl S300 size exclusion column. The elu-
tion profile was similar to those in Fig. 1, with 70% of
2Apro eluting with the highest molecular weight com-
plexes (HMW pool) and a smaller proportion (26%) hav-
ing the same elution time as a 17-kDa protein standard
(LMW pool). eIF4G cleavage activity eluted just before
the 17-kDa 2Apro peak (eIF4G cleavage pool) and con-
tained only a trace of 2Apro detectable by autoradiogra-
phy. Fractions containing peak levels of 2Apro or eIF4G
cleavage activity were separately pooled and compared
in their ability to cleave synthesized peptide substrates
derived from either the PV polyprotein or human eIF4G
(Table 2). As expected, the H-4G peptide was cleaved
significantly only when incubated with the eIF4G cleav-
age pool, thus reflecting the cleavage pattern observed
with eIF4G (RSW) cleavage assays. Again, significant
direct cleavage of the 4G peptide was not expected by
2Apro-enriched fractions (HMW pool and LMW pool) be-
cause molar excess of 2Apro did not exist in these as-
says. When the 2Apro-enriched fractions were tested with
the 1D2A substrate, significant, though incomplete,
cleavage was consistently observed in HMW and LMW
pools, demonstrating that active 2Apro was present in
these fractions as expected. Further, the 2Apro in HMW
and LMW pools exhibits the same preference for prote-
olysis of the 1D2A peptide over the H-4G peptide (e.g.,
26% versus 9% cleavage), as we previously showed us-
ing purified recombinant 2Apro (Bovee et al., 1998).
Interestingly, the fraction with peak levels of 4G-
cleavage activity also exhibited high cleavage activity
on the 1D2A substrate. These two peptides share 80%
sequence homology over the P4-P19 amino acid resi-
dues that provide the bulk of the substrate recognition
and specificity information for most cysteine pro-
teases. Therefore, just as 2Apro is capable of cleaving
the alternate eIF4G sequence, a cellular eIF4G-spe-
cific protease may be predicted to be capable of cleav-
age of a related 1D2A peptide with some efficiency.
However, it is also possible that the HMW and LMW
fractions may contain an inhibitor of 2Apro with partial
activity. The data in this figure cannot distinguish be-
tween these two possibilities. However, the demon-
stration of significant 2Apro activity in both HMW and
LMW fractions also indicates that if a protease inihibi-
tor is present, it is insufficient to effectively block 2Apro
activity. Also, a putative partial inhibitor cannot readily
explain the lack of eIF4G cleavage in those same
fractions. Further, the results also confirm that H-4G
peptide cleavage activity comigrates only with frac-
tions shown to catalyze eIF4G cleavage. Taken to-
gether, the simplest interpretation of the data is that
two cleavage activities exist and that a protease or
factor with high activity which does not comigrate with
2Apro is responsible for the majority of eIF4G- and
H-4G-specific proteolytic activity measurable in ly-
sates from infected cells.
Purification of eIF4G cleavage activity correlates
with loss of detectable 2Apro
Based on the above observations, efforts were fo-
cused on further purification of the eIF4G cleavage ac-
tivity. Table 3 lists the sequential steps developed for a
larger scale purification scheme. Viral proteins were ra-
diolabeled from 3.5 to 5 hpi before preparation of ex-
tracts for the purification process and active fractions
from each purification step were pooled and examined
by autoradiography for 2Apro or precursors such as
2ABC. Figure 2 shows analysis of the same purified
pools listed in Table 3 and shows that after the second
fractionation step, on Fast Q Sepharose, no radiolabeled
2Apro or unprocessed 2ABC precursor protein was de-
tectable in the pool that exhibited peak eIF4G cleavage
activity. Further purification over nickel and heparin col-
umns reduced the number of HeLa cell proteins detect-
TABLE 2









1D2A peptide 26% 84% 27%
H-4G peptide 9.3% 91% 11%
eIF4G 0% 97% 1%
Note. Cleavage assays are expressed as percentage cleavage of
input substrate peptide or eIF4G protein.
a Pooled fractions include apparent high-molecular-weight (HMW)
and low-molecular-weight (LMW) 2Apro fractions and the fraction con-
taining peak elF4G cleavage activity. The percentage of total 2Apro from
the starting S10 lysate that was present in each fractionated pool is
listed and was estimated from autoradiographs using NIH Image den-
sitometry software.
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able by silver stain to less than 20 (data not shown). This
further fractionation also removed all detectable viral
proteins except for a trace of 3CD which was revealed
only on a 19-day autoradiograph exposure (too faint to
reproduce well in Fig. 2). Although the precise quantita-
tion of cleavage activity was not possible from these
assays, the recovery of activity remained high after each
additional fractionation step. These data show that the
primary eIF4G cleavage activity in infected cell lysates
can be separated from all detectable traces of 2Apro and
comigrates with a small subset of HeLa cell proteins.
Quantitation of 2Apro from infected cell lysate
indicates an insufficient level for direct
proteolysis of eIF4G
In a previous report, we demonstrated that while in
vitro proteolysis of eIF4G can be directly catalyzed by
recombinant PV or CVB 2Apro, the reaction requires high
concentrations and molar excess of enzyme (Bovee et
al., 1998). If efficiency of the direct cleavage reaction
observed in vitro reflects direct eIF4G cleavage in vivo
(which is not known at this time) then similarly high molar
ratios of 2Apro to eIF4G should exist in lysates from
infected cells. Production of 2Apro is not detectable by
autoradiography of proteins from pulse-labeled cells un-
til after host protein shutoff occurs (near 2.5 hpi); then the
amount of 2Apro accumulates until 4.5 hpi (see Fig. 4).
Despite several attempts, 2Apro was undetectable by
conventional Western blot (which will detect as little as
80 ng 2Apro) at any timepoint during the infection (data
not shown). Therefore, a light-generating immunodetec-
tion system was used in 2Apro immunoblots (Super Sig-
nal Ultra, Pierce) which extended the assay sensitivity
over 50-fold. The 2Apro signal in S10 or P10 lanes was
calibrated against a dilution series of a known concen-
tration of recombinant 2Apro previously quantitated by
Coomassie stain relative to known standards (Bovee et
al., 1998). By comparison with purified eIF4G standards,
we have previously determined that 1 ml of S10 from
uninfected HeLa cells contains approximately 36 ng of
eIF4G, or about 0.23 pmol (Bovee et al., 1998). Figure 3
shows a titration of the soluble (S10) and insoluble (P10)
contents of PV-infected HeLa cells at 5 hpi, when the
highest levels of 2Apro have accumulated. The data show
that the total 2Apro synthesized in vivo was nearly equiv-
alently distributed between these compartments (as
shown in Table 1) and corresponded to a maximum of
about 1 ng/ml (0.06 pmol/ml) in each compartment (com-
pare lane 4 to lanes 9 and 12). In addition to reactivity to
2Apro, the polyclonal serum contains reactivity against a
bacterial protein which migrates near 20 kDa, and under
the Super Signal Ultra immunoblot conditions, a different
FIG. 2. Purification of eIF4G cleavage activity from radiolabeled
PV-infected HeLa cells. (A) eIF4G cleavage activity assays (lanes 2–5)
on material pooled at each purification step. Lanes contain: U, unincu-
bated RSW substrate control; C, RSW substrate incubated 2 h at 37°C
in the absence of material from infected cells; 1, 7 ml RSW from
PV-infected cells (eIF4G cleavage product marker); 2, Sephacryl S300
pool; 3, Fast Q Sepharose pool; 4, nickel-affinity pool; and 5, heparin–
Sepharose pool. Lanes 1–5 contain approximately 2.3, 0.5, 1.5, 1.5, and
3% of each respective total protein sample. Samples were subjected to
7% SDS–PAGE and transferred to nitrocellulose, and eIF4G (short
bracket) or its cleavage products (long bracket) were visualized by
immunoblot. (B) 4-day autoradiogram showing PV proteins detectable
in the corresponding pooled samples from A, lanes 2–5. The major PV
proteins are labeled.
TABLE 3








RSW-A cut 33 50 2.6
Sephacryl S300 9.4 175 56
Fast Q Sepharose 0.82 2,012 153
Nickel affinity 0.16 10,062 1687
Heparin-Sepharose 0.032 50,312 6250
a 0–40% (NH4)2SO4 precipitate of ribosomal salt wash typically aver-
ages 50-fold purification from crude HeLa cell lysate (by protein stain
(Pierce)).
b Activity estimated from immunoblots, defined as the amount of
cleavage activity required to cleave 50% of the eIF4G present in a
ribosomal salt wash sample in 90 min at 37°C.
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reactivity against an unknown HeLa protein also
emerged (Fig. 3, upper bands). Thus, the data from this
experiment reflected a molar enzyme to substrate ratio in
the cell at 5 h p.i. of approximately 1:4, which is approx-
imately 20-fold lower than ratios which were found to be
required to catalyze complete direct cleavage of eIF4G in
vitro with purified recombinant PV, CVB4, or HRV2 2Apro
produced in several laboratories (Bovee et al., 1998;
Haghighat et al., 1996). The levels of 2Apro in cells during
the early period of 1.5–2.5 h pi when eIF4G is actually
cleaved are unknown, but will be significantly lower than
1 ng/ml (see Fig. 4).
Reduction of 2Apro synthesis in infected cells does
not delay eIF4G proteolysis
The molar enzyme to substrate ratio in infected cells
can be altered by infecting HeLa cells with PV in the
absence or presence of 2 mM guanidine, which drasti-
cally inhibits viral RNA replication through its effect on
FIG. 3. Quantitation of 2Apro from PV-infected HeLa lysate at 5 hpi. Cells infected in the absence or presence of 2 mM guanidine were lysed and
processed into soluble (S10) and insoluble (P10) compartments. Each sample was titrated on 12% SDS–PAGE along with recombinant 2Apro of known
concentration (see Materials and Methods) and visualized on X-ray film using a light-generating immunoblot procedure. Upper bands migrating at
20 kDa in Escherichia coli preparations (lanes 1–6) or at 19 kDa in HeLa lysate (lanes 7–18) are unrelated cellular proteins that react with IgG in the
same serum. Positions of 2Apro and molecular weight standards are indicated.
FIG. 4. eIF4G cleavage kinetics and host cell shutoff in PV-infected HeLa cells. (Top) Western blot with eIF4G antiserum shows distribution of intact
(4G) and cleaved (c.p.) eIF4G at 20 min intervals from 0 to 5 hpi. (Lane M) eIF4G from mock-infected cells. (Bottom) Autoradiogram from a pulse label
experiment shows proteins synthesized during 20-min intervals from 0 to 5 hpi. (Lane M) Position of 2Apro is indicated in the PV protein marker.
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the function of viral protein 2C (Baltera and Tershak,
1992; Tolskaya et al., 1994). By eliminating the amplifica-
tion of viral RNA, guanidine also greatly reduces the
production of 2Apro and all other viral proteins in infected
cells since only the input virion mRNA can be translated.
Samples from infected cells were monitored at 20-min
intervals to examine the kinetics of 2Apro expression and
the extent of eIF4G proteolysis, as described under Ma-
terials and Methods. Figure 4 shows that in the absence
of guanidine, synthesis of 2Apro first became detectable
at 160 min pi, concurrent with the shutoff of cellular
protein synthesis. eIF4G cleavage was first observed at
100 min pi, 60 min before 2Apro was detected. Figure 5
shows that addition of guanidine to infected cells re-
duced production of all viral proteins to levels below
detection by autoradiography, as expected. We wished to
determine whether 2Apro could be detected before 160
min in control infections, or at any timepoint for cells
infected in the presence of guanidine, in case significant
levels were present but simply masked by the translation
FIG. 6. Completion of eIF4G cleavage coincides with earliest detection of 2Apro by immunoprecipitation. All pulse label samples shown in Figs. 4
and 5 were subjected to immunoprecipitation as described under Materials and Methods and 2Apro was visualized by 12% SDS–PAGE and
autoradiography. Autoradiographs were exposed for 5 weeks, resulting in detection of two background HeLa proteins.
FIG. 5. eIF4G cleavage kinetics and host cell shutoff during infection in the presence of guanidine. Same as legend to Fig. 4, except the virus
infection contained 2 mM guanidine, as described under Materials and Methods.
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of cellular proteins. To test this, radioimmunoprecipita-
tion (RIP) was performed on pulse-labeled samples from
the infections shown in Figs. 4 and 5. Figure 6 shows that
RIP extended the earliest detection of 2Apro in a normal
infection to 120 min pi, 40 min earlier than on autoradio-
graphs alone (compare with Fig. 4); however, 2Apro was
undetectable in guanidine-treated cells by this method at
any timepoint, even upon extended exposures (Fig. 6).
Figure 3 also shows that accumulation of 2Apro was
undetectable by immunoblot methodology at 5 hpi in
lysates from guanidine-treated cells (lanes 13–18). The
precise amounts of 2Apro produced in these cells is not
known but is at least 20-fold reduced by guanidine treat-
ment (Fig. 3).
Importantly, addition of guanidine caused only a slight
change in the kinetics of eIF4G cleavage. With or without
guanidine, the onset of eIF4G cleavage was first detect-
able at the same time, 100 min pi, although complete
cleavage in guanidine-treated cells was delayed slightly.
In either case, eIF4G cleavage began before production
of 2Apro was detectable. Therefore, rapid, efficient eIF4G
cleavage occurs in vivo under conditions where 2Apro is
completely undetectable. Also, as previously shown by
others, complete proteolysis of all detectable eIF4G did
not result in complete host cell translation shutoff, sug-
gesting that complete shutoff of cellular translation re-
quires at least one event in addition to eIF4G cleavage
(Bonneau and Sonenberg, 1987; Lloyd et al., 1987; Pe´rez
and Carrasco, 1992).
In vitro eIF4G cleavage activity in cellular lysates is
not diminished by reduction in levels of 2Apro
We also examined the effect of altering the molar ratio
of 2Apro and eIF4G in cell lysates on the in vitro eIF4G
cleavage activity. Thus, the predominant eIF4G cleavage
activity was measured in lysates from control or guani-
dine-treated infected cells. Figure 7 shows that guani-
dine treatment caused no discernable reduction in the
level of in vitro eIF4G cleavage activity detected in any of
the three subcellular compartments which were as-
sayed, despite the corresponding reduction in 2Apro.
Taken together, these data support the conclusion that
the efficient in vitro cleavage of eIF4G measured in vivo
and in vitro does not arise from direct catalysis by 2Apro
and likely involves a cellular factor.
DISCUSSION
It is now generally accepted that 2Apro is the only viral
protein required for cellular translation shutoff to occur
and that the hallmark of this phenomenon is the prote-
olysis of eIF4G. It was originally proposed based on
subcellular fractionation experiments and antibody inhi-
bition studies that eIF4G was cleaved in PV-infected
HeLa cells via an indirect mechanism involving activa-
tion of a cellular factor (Kra¨usslich et al., 1987; Lloyd et
al., 1986). More recently investigations by independent
researchers using highly purified eIF4G and CVB4 and
HRV2 proteases have clearly shown that eIF4G can be
cleaved in vitro by CVB or HRV 2Apro alone, at a region
bearing conserved amino acids important for 2Apro sub-
strate recognition on the viral polyprotein (Lamphear et
al., 1993; Sommergruber et al., 1994). Based on this
observation it was proposed that eIF4G cleavage was
catalyzed directly by 2Apro in infected cells. This direct
mechanism for eIF4G cleavage is very appealing in its
simplicity, but conflicts with the earlier observations in
which subcellular fractionation of HeLa cell lysates sep-
arated eIF4G cleavage activity from the majority of 2Apro
(Lloyd et al., 1986).
In an effort to determine if PV used a different eIF4G
cleavage mechanism than that used by CVB and HRV, we
have recently performed new studies which showed that
purified, active PV and CVB 2Apro both are capable of direct
cleavage of purified eIF4G; however, each reaction was
inefficient, requiring high enzyme concentrations and a mo-
lar excess of enzyme to catalyze complete cleavage (Bovee
et al., 1998). This result mechanistically unified the PV and
CVB experimental models but also raised questions re-
garding the physiological significance of the direct cleav-
age mechanism since complete cleavage of eIF4G in in-
FIG. 7. Efficient in vitro cleavage of eIF4G in the absence of detectable levels of PV 2Apro. Infected cells were processed as previously described
and then combined with exogenous intact eIF4G present in the RSW fraction from uninfected HeLa cells (U-RSW). Cleavage assays were stopped
after 120 min at 37°C by boiling in denaturing gel loading buffer. Samples were then subjected to SDS–PAGE and immunoblotted as described above.
U-RSW before (0) and after (120) incubation.
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fected cells is very rapid and occurs before 2Apro is readily
detectable. It is possible that in vitro measurements of
eIF4G cleavage activity catalyzed by 2Apro do not accurately
reflect the same reaction in vivo or that there is a more
efficient mechanism involving some other cellular factor
operating in vivo.
In this report, which focused on the eIF4G cleavage
activity measurable in infected HeLa lysates, we showed
that PV-infected cells contain an activity which causes
eIF4G cleavage, but that this cleavage activity segre-
gates from the majority of active 2Apro by several types of
chromatography. Further, the eIF4G cleavage activity can
be highly purified into fractions containing several host
proteins but no trace of 2Apro or its precursor 2ABC. We
also showed that the 2Apro in HeLa cell lysates was
catalytically active against a peptide containing the 2A
cleavage sequence from the PV polyprotein but does not
accumulate to levels high enough to cause measurable
eIF4G cleavage in in vitro assays. Finally, the inclusion of
guanidine to severely limit production of 2Apro during
infection caused no significant delay in the rapid and
specific cleavage of eIF4G in vivo. Taken together, these
data are not easily reconcilable with a predominantly
direct mechanism of eIF4G cleavage in vivo and instead
strongly suggest the involvement of at least one cellular
factor, which is likely to be a protease. We have com-
pleted similar experiments with CVB4-infected HeLa
cells which also resulted in separation of 2Apro from the
dominant eIF4G-specific cleavage activity (unpublished
observations). It therefore seems likely that all species of
enteroviruses utilize a common indirect mechanism for
the rapid, complete, in vivo proteolysis of eIF4G.
It is likely that eIF4G cleavage in vivo is catalyzed via
both direct and indirect mechanisms simultaneously;
however, for a direct cleavage mechanism to be respon-
sible for the dominant cleavage activity measured in
HeLa lysates, an unknown form of 2Apro with much
higher specific activity for eIF4G must exist in cells, or an
alternate form of substrate which has not yet been de-
scribed or tested is required to enhance direct cleavage
reactions (i.e., not purified eIF4G alone or eIF4G found in
eIF4F or eIF4F/eIF3 complexes) (Bovee et al., 1998;
Haghihat et al., 1996; Lamphear et al., 1993). Some in-
vestigators have proposed that a cellular protein may
interact with 2Apro to massively increase its cleavage
activity on eIF4G by either binding 2Apro to alter cleavage
activity or imparting a covalent modification such as a
cleavage event on 2Apro. Although this remains a formal
possibility, some radiolabeled 2Apro should copurify and
be concentrated and enhanced over the course of an
extensive purification of eIF4G cleavage activity; this has
not been seen despite numerous attempts using a large
variety of purification schemes.
The data here suggest that indirect cleavage involves
a much more efficient catalytic reaction and this activity
predominates over the native 2Apro direct cleavage re-
action in infected cells. Indeed, our efforts to identify the
cellular proteolytic activity in these fractions has proven
extremely difficult because of the apparent high specific
activity of this enzyme. A two-step or multiple step eIF4G
cleavage reaction is very appealing since it greatly in-
creases the efficiency of eIF4G cleavage beyond the
capabilities of 2Apro alone. Further, there is ample pre-
cedence for proteolytic activation cascades throughout
biology in the mechanisms of fibrin deposition, comple-
ment activation, activation of digestive proteases, and
more recently, activation of intracellular caspases during
apoptosis (Faleiro et al., 1997).
It is possible that enteroviruses have gained the
capability of activating a cellular protease(s) which is
normally involved in the regulation of translation or
some other process in the uninfected cell. Indeed, the
generation of similar eIF4G cleavage products during
purification of initiation factors from uninfected cells
has been a common unreported problem (data not
shown). Further, there have been previous reports of
cellular proteases which cleave eIF4G in uninfected
cells, including calpain and an activity induced in
hemin-differentiated K562 cells (Benton et al., 1996;
Wyckoff et al., 1990). In this regard, we have recently
discovered that eIF4G is targeted for proteolytic cleav-
age during the execution phase of apoptosis in unin-
fected cells and that at least two distinct cellular
eIF4G-specific proteases are activated (submitted for
publication). One of these activities produces cleav-
age products which comigrate with eIF4Gcp from po-
liovirus-infected cells (submitted for publication). We
are pursuing the possibility that the predominant
eIF4G cleavage activity described here may be a
caspase activated by poliovirus infection instead of
apoptosis.
It is interesting to speculate how two modes of eIF4G
cleavage evolved. Recent studies have shown that eIF4G
must be in a form complexed with eIF4E to serve as a
substrate for 2Apro (Haghighat et al., 1996; Ohlmann et
al., 1997). In contrast, the apparent cellular protease
activated by 2Apro efficiently cleaves all the eIF4G
present in lysates, in all its possible forms. Finally, we
have recently shown in a K562 persistent infection model
that complete cleavage of eIF4G and development of
host translation shutoff are not required for viral RNA
replication and growth. In contrast, the ability to cause
complete shutoff was closely linked to cell lysis (Benton
et al., 1995; Benton et al., 1996; Lloyd and Bovee, 1993).
Thus it is possible that enteroviruses acquired the ability
to cause complete cleavage of eIF4G and host transla-
tion shutoff in an effort to aid lysis and viral spread
and/or to quickly block development of interferon re-
sponses in the alimentary tract. Thus, the phenomenon
of host translation shutoff may exist primarily for viral
pathogenesis.
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MATERIALS AND METHODS
Cells and virus
HeLa S3 tissue culture cells originally obtained from
the American Type Culture Collection were grown at
37°C in Joklik’s SMEM supplemented with 9% bovine calf
and 1% fetal bovine serum at a density ranging from 2 3
105 to 8 3 105 cells per milliliter. Poliovirus type 1 (Ma-
honey strain) was cultivated in HeLa cells and purified as
previously described (Jones and Ehrenfeld, 1983). De-
pending on the experiment, infections were carried out at
multiplicities of infection of 30- or 100 PFU/cell in a 37°C
recirculating water bath.
Radiolabeling of viral proteins
Viral proteins were radiolabeled in vivo by incubating
infected HeLa cells in methionine-free SMEM prior to ad-
dition of [35S]tran label (ICN Radiochemicals) to a final
concentration of 30 mCi per ml. Cells were pulse labeled for
30 min prior to lysis in RSB/NP-40 buffer (10 mM Tris–Cl, pH
7.4, 10 mM NaCl, 1.5 mM MgCl2, 1% NP-40). Cells were then
vortexed briefly and insoluble material was removed by
centrifugation. The supernate was added to an equal vol-
ume of SDS–PAGE loading buffer (43 stock contains 26
mM DTT, 60 mM Tris at pH 6.8, 40% glycerol, 6% SDS) and
heated to 95°C for 3 min before resolution on 12% SDS–
PAGE. For biochemical assays requiring detection of
minute quantities of viral proteins, radiolabel was incorpo-
rated from 3.5 to 5 hpi. Cells were then harvested by
centrifugation, washed in cold Earle’s balanced salt solu-
tion, and resuspended on ice in a hypotonic buffer (10 mM
Hepes, pH 7.4, 10 mM KCl, 1.5 mM MgOAc, 1 mM DTT) prior
to lysis in a Dounce cell homogenizer. The protease inhib-
itor phenylmethylsulfonyl fluoride was added immediately
after lysis to a final concentration of up to 0.5 mM to inhibit
nonspecific proteolytic activity. The resulting lysate was
centrifuged for 15 min at 10,000g and the supernate (S10)
was collected and stored at 270°C or further processed as
described below.
Purification of eIF4G-specific cleavage activity
One-step separation of 2Apro from eIF4G cleavage
activity was obtained using a high-resolution G3000SW
gel filtration column (TosoHaas). Proteins in the postri-
bosomal supernate fraction or in the ribosomal salt wash
were precipitated by addition of saturated ammonium
sulfate to 40% and then resolubilized, as previously de-
scribed (Brown and Ehrenfeld, 1980). The samples were
resuspended in buffer H (Wyckoff et al., 1992), and 500 ml
was applied to the column, previously equilibrated in the
same buffer. 2Apro was detected by SDS–PAGE, followed
by autoradiography for up to 25 days. eIF4G cleavage
activity was measured as described below.
Radiolabeled S10 lysate was fractionated at 1 ml/min
on a Sephacryl S300 column (10 3 440 mm) also equil-
ibrated in buffer H, and 0.5-ml fractions were collected.
2Apro was detected on autoradiograms of dried SDS–
PAGE gels. 2Apro or eIF4G cleavage activity (described
below) in the column fractions was then assayed for
cleavage of synthetic peptide substrates.
The following procedure was used for high-level purifi-
cation of eIF4G cleavage activity from infected cells. The
RSW A-cut fraction was prepared as described above and
applied to a Sephacryl S300 column (10 3 440 mm) equil-
ibrated in a buffer containing 20 mM Tris–Cl, pH 8.0, 30 mM
KCl, 10% glycerol. Eluted fractions containing peak eIF4G
cleavage activity were pooled and subjected to Fast Q
Sepharose (Pharmacia) anion exchange chromatography
(buffered by 25 mM KCl, 20 mM Tris, pH 8.0, 10% glycerol).
Bound proteins were eluted in a gradient of 0.025 to 1 M
KCl in the same buffer. Again, fractions containing cleavage
activity were pooled and applied to a 1-ml nickel affinity
column (Hi-Trap IMAC, Pharmacia) adjusted to 100 mM
NaCl, 20 mM Tris–HCl, pH 8.0, 10% glycerol. Bound proteins
were eluted with a 25 to 50 mM stepwise gradient of EDTA
in the same buffer, and fractions exhibiting eIF4G cleavage
activity were combined. Finally, this sample was applied to
a 1-ml heparin–Sepharose (HiTrap Heparin, Pharmacia)
column, to which bound the majority of total protein, and
cleavage activity was detected only in the flow-through
fraction.
Measurement of eIF4G cleavage activity
eIF4G cleavage activity was detected by combining 90
ml of the indicated column fractions with 7 ml of RSW
from uninfected HeLa cells, which is highly enriched for
eIF4G. One hundred-microliter reactions also contained
5 mM MgCl2 and 50 mM NaCl and were incubated 1.5 to
2 h at 37°C. Resulting samples were boiled in SDS–
PAGE loading buffer and resolved on 7% SDS–PAGE,
then transferred to nitrocellulose and subjected to immu-
noblot analysis using a polyclonal antiserum raised
against human eIF4G. Cleavage assays on samples
pooled during high-level purification of eIF4G cleavage
activity were incubated for 2 h at 37°C and contained the
following: 7 ml eIF4G substrate (dialyzed RSW from un-
infected cells), 30 ml of active material pooled from the
respective columns, and 5 ml of salt buffer containing 50
mM MgCl2 and 0.5 M NaCl. The RSW used in these
assays was dialyzed for 2 h at 4°C in buffer containing 20
mM Tris–Cl, pH 7.6, 100 mM KCl, 7 mM 2-ME, 0.2 mM
EDTA, and 10% glycerol. Then 150 ml from each column
pool was further analyzed on 12% SDS–PAGE and auto-
radiographed for 4 or 19 days, as indicated in the text
and Fig. 2. In certain instances, dilutions of cellular
fractions were tested for cleavage activity by immunoblot
analysis and percentage cleavage was determined by
densitometric analysis of scanned immunoblots with
NIH Image software.
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Peptide cleavage assays
Sephacryl S300 column fractions (90 ml) were individ-
ually combined with 20 mg of a peptide derived either
from the native 2A cleavage site in the viral polyprotein
(1D2A) or from the previously mapped 2Apro cleavage
site on human eIF4G (H-4G). The 150-ml reactions were
incubated for 2 h at 30°C. Samples were processed
essentially as described previously (Bovee et al., 1998),
except reactions were stopped with HClO4 instead of
trichloroacetic acid. Peptides were resolved on a C-18
Ultrasphere reverse-phase HPLC column (Beckman) as
described previously (Bovee et al., 1998).
Quantitation of 2Apro from infected cells
Infected HeLa cells were harvested at 5 hpi and lysed
in a Dounce cell homogenizer as described above. The
lysate was fractionated by centrifugation into soluble
(S10) and insoluble (P10) compartments. These fractions
were then subjected to SDS–PAGE followed by chemilu-
minescent Western blotting (Super Signal Ultra, Pierce)
in comparison with a dilution series of recombinant PV
2Apro previously quantitated by Coomassie stain. X-ray
film (type MR, Kodak) was exposed to the luminescent
immunoblot for 4 min and developed.
Poliovirus infection in the presence or absence of 2
mM guanidine
HeLa cells were infected with poliovirus, thoroughly
mixed, and then divided equally into two tubes. A 1000-
fold dilution of 2 M guanidine-HCl in distilled water was
immediately added to one of the tubes, and the split
infections were gently stirred in a 37°C recirculating
water bath. Two samples were taken from each tube at
20-min intervals from 0 to 5 hpi. One aliquot (5 3 105
cells) was pulse labeled for 20 min by resuspension in
100 ml methionine-free medium containing 50 mCi/ml
[35S]tran label and processed as described above, prior
to 12% SDS–PAGE and autoradiography. The second
aliquot (1 3 106 cells) was quickly resuspended in the
lysis buffer and processed in the manner described
above, in preparation for analysis on 7% SDS–PAGE
followed by immunoblotting for eIF4G.
Immunoprecipitation of 2Apro
Fifteen microliters of each 20-ml pulse label sample
was diluted into 1.5 ml ice-cold IP buffer (10 mM
Tris–Cl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% NP-40),
to which 2.5 ml of polyclonal 2Apro antiserum (Benton
et al., 1995) was added, and rocked overnight at 4°C.
One hundred microliters of a 10% Protein A–agarose
(Sigma) slurry, in the same buffer, was added to each
sample and rocked for an additional 4 h at 4°C. The
Protein A beads were then sedimented and washed
five times in cold IP wash buffer (50 mM Tris–Cl, pH
7.4, 500 mM NaCl, 5 mM EDTA, 5% sucrose, 1% NP-40)
and then boiled in 20 ml SDS–PAGE loading buffer for
12% SDS–PAGE analysis and autoradiography. X-ray
film was exposed for up to 5 weeks to assure detec-
tion of 2Apro near background levels.
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